Industry should view both proposed legislation and arguments against it with a critical eye, but let’s address legitimate concerns while dismissing strawmen.
By Steve Mister, President & CEO, Council for Responsible Nutrition04.26.22
Sen. Dick Durbin (D-IL) and Sen. Mike Braun (R-IN) introduced a bill that would require dietary supplement manufacturers to file product information with FDA.
Utah’s longest-serving Senator was known for working across the aisle, authoring or coauthoring some of the most consequential laws of the past half century.
The U.S. Food and Drug Administration is prioritizing multiple ways to regulate the dietary supplements industry in its request for an $8.4 billion budget.
Trial finds modest reduction in cardiovascular events for those taking cocoa extract, no association between multivitamins and reduced risk of cancer or CVD.
The agency has called into question the amino acid metabolite’s legal status as a dietary ingredient, counter to the opinions of several industry leaders.
Following a review of the evidence, FDA now supports three types of claims on the research, which it still considers to be “inconsistent and inconclusive.”
After issuing warning letters to companies claiming that NAC is excluded as a dietary ingredient, the agency's response to citizen petitions is still tentative.
Wommack, who currently serves as CRN’s senior vice president, will follow the foundation’s plan to prioritize access to nutritional products and education.
FDA raised objections to the use of N-acetylcysteine in supplements in Dec. 2020, and since, Amazon has pulled all NAC-containing products from its platform.
Focus centered around the GRAS and NDI processes, the prospects of a mandatory product listing, how health claims will be handled in the future, and more.
Several claims and consumer testimonials claimed that a multivitamin supplement could improve children’s behavioral issues such as hyperactivity and tantrums.
Promotions include Holly Vogtman to director of communications, Rashidah Denton to manager of scientific and regulatory affairs, and Gretchen Powers’ expanded role to include member experience.
While the agency has not specifically confirmed it, dietary supplements were not mentioned in a list of manufacturers required to enhance traceability measures.
Ridley’s responsibilities will be to spearhead the association’s communications program, build key partnerships, and craft education and advocacy campaigns.
FDA currently prohibits the use of NAC as a dietary supplement, and is concerned about a proposal for HHS to review certain regulations or let them expire.